Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-037529
Filing Date
2012-06-21
Accepted
2012-06-21 16:02:19
Documents
1
Period of Report
2012-06-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd349248.html 4  
1 FORM 4 rrd349248.xml 4 4004
  Complete submission text file 0001181431-12-037529.txt   5390
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DYNAVAX TECHNOLOGIES CORP 2929 SEVENTH ST STE 100 BERKELEY CA 94710
Business Address
COFFMAN ROBERT (Reporting) CIK: 0001278710 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34207 | Film No.: 12919805